Trinity Biotech plc (TRIB)
| Previous Close | 2.9500 |
| Open | 2.9200 |
| Bid | 2.7900 x 100 |
| Ask | 2.9200 x 100 |
| Day's Range | 2.8006 - 2.9500 |
| 52 Week Range | 1.4900 - 4.9500 |
| Volume | |
| Avg. Volume | 54,795 |
| Market Cap | 27.071M |
| Beta (5Y Monthly) | 1.31 |
| PE Ratio (TTM) | 0.67 |
| EPS (TTM) | 4.2500 |
| Earnings Date | May 23, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jun 05, 2015 |
| 1y Target Est | N/A |
GlobeNewswireTrinity Biotech Announces Appointment of A New CFO
DUBLIN, July 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the appointment of Louise Tallon as Chief Financial Officer (“CFO”). Louise will join Trinity Biotech in August 2024. Des Fitzgerald, who has acted as interim CFO since December 2023 will continue as interim CFO until late July 2024. Commenting on the appointment, John G
- GlobeNewswire
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (“CGM”) solution towards market launch. Since acquiring the CGM technology earlier in the year, Trinity Biotech has been working on further innovations and improvements to the original device. The Company
- GlobeNewswire
Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to attend the 84th Scientific Sessions of the American Diabetes Association in Orlando Florida, taking place on June 21-24, 2024. Management plans to host meetings with key stakeholders and potential partners as it works t
